Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PIPRA is a Swiss healthtech company that has developed a clinically validated, AI-based software tool to assess the risk of postoperative delirium (POD) in elderly patients. By analyzing routine clinical data, the tool identifies high-risk patients before surgery, allowing clinicians to implement targeted preventive measures. The company's mission is to reduce the incidence of POD, which is a common and costly complication associated with increased mortality and long-term cognitive decline. PIPRA's solution is integrated into hospital workflows as a Software as a Medical Device (SaMD) and is currently being deployed across European healthcare systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PIPRA.